Preview

Problems of Endocrinology

Advanced search

Radioiodine therapy for benign thyroid diseases

https://doi.org/10.14341/probl200652243-47

Abstract

There are 3 alternative methods of treating benign thyroid diseases that occur with thyrotoxicosis syndrome: medication, surgery, and radioiodine therapy. However, there are some features in the approaches to the treatment of autoimmune and non-immune hyperthyroidism.

About the Authors

L. I. Danilova

Belarusian Medical Academy of Postgraduate Education


Belarus


V. V. Valuyevich

Belarusian Medical Academy of Postgraduate Education


Belarus


References

1. Данилова Л. И. Болезни щитовидной железы и ассоциированная с ними патология. -Минск, 2005.

2. Фадеев В. В.//Пробл. эндокринол. -2004. -№ 2. -С. 47-53.

3. Фадеев В. В., Дроздовский Б. Я., Гусева Т.Н. и др.//, Пробл. эндокринол. -2005. -№ 1. -С. 3-10.

4. Abe Y, Sato Н., Noguchi М. et al.//Wld J. Surg. -1998. -Vol. 22.-P. 714-717.

5. Allahabadia A., Daykin J., Holder R. L. et al.//J. Clin. Endocrinol. Metab. -2000. -Vol. 85. -P. 1038-1042.

6. Allahabadia A., Daykin J., Sheppard M. C et al.//J. Clin. Endocrinol. Metab. -2001. -Vol. 86. -P. 3611-3617

7. Andrade V. A., Gross J. L., Maia A. L.//J. Clin. Endocrinol. Metab. -2001. -Yol. 86. -P. 3488-3493.

8. Angusti Т., Codegone A., Pellerito R., Favero A.//J. Nucl. Med. -2000. -Vol. 41. -P. 1006-1009.

9. Bahre M., Hilgers R., Lindemann C, Emrich D.//Acta Endocrinol. -1988. -Vol. 177. -P. 145-153.

10. Bartalena L., Marcocci C, Pinchera A.//Bailliere's Clin. Endocrinol. Metab. -1997. -Vol. 11. -P. 521-536.

11. Bartalena L., Marcocci C, Bogazzi F. et al.//N. Engl. J. Med. -1998. -Vol. 338. -P. 73-78.

12. Bartalena L, Marcocci C, Tanda M. L. et al.//Ann. Intern. 'Med. -1998. -Vol. 129. -P. 632-635.

13. Bartalena L., Marcocci C, Pinchera A.//Graves' Disease -Pathogenesis and Treatment/Eds B. Rapoport, S. M. McLachlan. -Boston, 2000. -P. 279-288.

14. Beckers C.//Thyroid. -1997. -Vol. 7. -P. 221-224.

15. Bell E., Grunwald F. Radiojodtherapie bei benignen und malignen Schilddrulsenerkrankungen. -Berlin, 1999.

16. Bonnema S. J., Bartalena L, Toft A. D., Hegedus L.//Eur. J. Endocrinol. -2002. -Vol. 147. -P. 1-11.

17. Braga M., Walpert N, Burch H. B. et al.//Thyroid. -2002. -Vol. 12. -P. 135-139.

18. Calegaro J. U., de Freitas-Gomes E., Bae S. H. et al.//Panminerva Med. -2000. -Vol. 42. -P. 241-245.

19. Dietlein M., Schicha H.//Fortschr. Med. -2003. -Bd 145. -S. 47-49.

20. Dietlein M., Dressier J., Grunwald F. et al.//Nuklearmedizin. -2004. -Bd 43. -S. 217-220.

21. Diez J.J.//Gerontology. -2003. -Vol. 49, N 5. -P. 316-323.

22. Duh Q.-Y.//Thyroid. -1999. -Vol. 9. -P. 259-261.

23. Duick D. S., Baskin H. J.//Endocr. Pract. -2003. -Vol. 9. -P. 204-209.

24. Dunkelmann S., Endlicher D., Prillwitz A. et al.//Nuklearmedizin. -1999. -Bd 38. -S. 131-139.

25. Farrar J. J., Toft A. D.//Clin. Endocrinol. -1991. -Vol. 35. -P. 207-212.

26. Franklyn J. A.//N. Engl. J. Med. -1994. -Vol. 330. -P. 1731-1738.

27. Hamilton J. G., Lawrence J. H.//J. Clin. Invest. -1942. -Vol. 21. -P. 624 (Abstr.).

28. Hancock L. D., Tuttle R. M., LeMar H. et al.//Clin. Endocrinol. -1997. -Vol. 47. -P. 425-430.

29. Hertz S, Roberts A.//J. Clin. Invest. -1942. -Vol. 21. -P. 624 (Abstr.).

30. Hollowell J. G., Staehling N. W., Banders W. D. et al.//J. Clin. Endocrinol. Metab. -2002. -Vol. 87. -P. 489-499.

31. Holm L. E., Hall P., Wiklund K. et al.//J. Natl. Cancer Inst. -1991. -Vol. 83. -P. 1072-1077.

32. Huysmans Dyde A, Nieuwlaat Willy-Anne, Hermus Ad. R.//Clin. Endocrinol. -2004. -Vol. 60. -P. 297-299.

33. Ikekubo K., Kusakabe K., Kanaya S. et al.//Kaku Igaku. -2003. -Vol. 40, N 4. -P. 457-463.

34. Imseis R. E, Vanmiddlesworth L, Massie J. D. et al. // J. Clin. Endocrinol. Metab. - 1998. - Vol. 83. - P. 685-687.

35. Jonsson H., Mattsson S.//Radiat. Prot. Dosimetry. -2004. -Vol. 108, N2.-P. 107-114.

36. Kalinyak J. E., McDougall I. R.//J. Clin. Endocrinol. Metab. -2003. -Vol. 88. -P. 975-977.

37. Kapucu L. O., Azizoglu F., Ayvaz G., Karakok А.//Eur. J. Nucl. Med. -2003. -Vol. 30, N 9. -P. 1270-1272...

38. Karlsson A. F, Dahlberg P. A., Jansson R. et al.//Acta Endocrinol. -1989. -Vol. 121. -Suppl. 2. -P. 132-141.

39. Kok S. W., Smit J. W, de Craen A. J. et al.//Nucl. Med. Commun. -2000. -Vol. 21. -P. 1071-1078.

40. Korber C, Schneider P., Korber-Hafner N. et al.//Eur. J. Nucl. Med. -2001. -Vol. 28. -P. 1360-1364.

41. Kubota S, Tamai H, Ohye H. et al.//Endocr. J. -2004. -Vol. 51. -P. 213-217.

42. Langhammer H. R.f Laubenbacher C, Hirsch C. et al.//Med. Klin. -1999. -Bd 94. -S. 415-424.

43. Lind P.//Eur. J. Nucl. Med. -2002. -Vol. 29. -Suppl. 2. -P. 453-457.

44. Ljunggren J.-G, Toning O., Wallin G. et al.//Thyroid. -1998. -Vol. 8. -P. 653-659.

45. Manso P. G., Furlanetto R. P., Wolosker A. M. B. et al.//Thyroid. -1998. -Vol. 8. -P. 49-52.

46. Marcocci C, Bartalena L., Bogazzi F. et al.//Thyroid. -1992. -Vol. 2. -P. 171-178.

47. Michelangeli V., Poon C, Taft J. et al.//Thyroid. -1998. -Vol. 8.-P. 119-124.

48. Moka D., Dietlein M., Schicha H.//Eur. J. Nucl. Med. -2002. -Vol. 29. -Suppl. 2. -P. 486-491. "

49. Read C. H. Jr., Tansey M. J., Menda Y.//J. Clin. Endocrinol. Metab. -2004. -Vol. 89, N 9. -P. 4229-4233.

50. Reiners C.//Z. Arztl. Fortbild. -1999. -Bd 93. -S. 61-66.

51. Reinhardt M. J., Brink I., Joe A. Y. et al.//Eur. J. Nucl. Med. -2002. -Vol. 29, N 9. -P. 1118-1124.

52. Reinhardt M. J., Joe A., von Mallek D. et al.//Eur. J. Nucl. Med. -2002. -Vol. 29, N 4. -P. 480-485.

53. Richtlinie Strahlenschutz in der Medizin 2002. Richtlinie nach der Verordnung uber den Schutz vor Schaden durch ionisierende Strahlen (Strahlenschutzverordnung -StrlSchV). Ausgabe mit ausfuhrlichem Erlauterungsteil. -5. Aufl. -Kemmer W., Michalczak H. -Berlin, 2003.

54. Ron E., Doody M. M., Becker D. V. et al.//J. A. M. A. -1998.-Vol. 280. -P. 347-355.

55. Sabri O., Zimmy M., Schulz G. et al.//J. Clin. Endocrinol. Metab. -1999. -Vol. 84. -P. 1229-1233.

56. Sabri O., Zimny M., Buell U.//Eur. J. Nucl. Med. -2001. -Vol. 28. -P. 1360-1364.

57. Sawin С. Т., Geller A., Kaplan M. M. et al.//Arch. Intern. Med. -1991. -Vol. 151. -P. 165-168.

58. Schicha H., Dietlein M.//Nuklearmedizin. -2002. -Bd 41. -S. 63-70.

59. Shih W. J., Mitchell В., Schott J. C.//J. Natl. Med. Assoc. -2002. -Vol. 94. -P. 915-919.

60. Stridama V., DeGroot L. J.//Am. J. Med. -1989. -Vol. 87. -P. 70-73.

61. Tallstedt L, Lundell G., Torring O. et al.//N. Engl. J. Med. -1992. -Vol. 326. -P. 1733-1738.

62. Tallstedt L, Lundell G., Blomgren H., Bring J.//Eur. J. Endocrinol. -1994. -Vol. 130. -P. 494-497.

63. Tunbridge W. M. G., Evered D. C, Hall R. et al.//Clin. Endocrinol. -1977. -Vol. 7. -P. 481-493.

64. Tuttle R. M., Patience Т., Budd S. Ц Thyroid. -1995. -Vol. 5. -P. 243-247.

65. Urbannek V., Voth E, Moka D., Schicha H. ff Nuklearmedizin. -2001. -Bd 40. -S. 111-115.

66. Vanderpump P. J., Tunbridge W. M. G.//Thyroid. -2002. -Vol. 12. -P. 839-847.

67. Vitti P., Rago Т., Chiovato L. et al.//Thyroid. -1997. -Vol. 7. -P. 369-375.

68. Walter M. A., Christ-Crain M., Eckard B. et al.//Eur. J. Clin. Invest. -2004. -Vol. 34, N 4. -P. 365-370.

69. Weetman A. P.//N. Engl. J. Med. -2000. -Vol. 343. -P. 1236-1248.

70. WHO, UNICEF, and ICCIDD. Progress Towards the Elimination of Iodine Deficiency Disorders (IDD). -Geneva, 1999.-P. 1-33.

71. Williams E. D.//The Thyroid: A Fundamental and Clinical Text/Eds L. E. Braverman, R. D. Utiger. -6-th Ed. -Philadelphia, 1995. -P. 421-436.


Review

For citations:


Danilova L.I., Valuyevich V.V. Radioiodine therapy for benign thyroid diseases. Problems of Endocrinology. 2006;52(2):43-47. (In Russ.) https://doi.org/10.14341/probl200652243-47

Views: 3844


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)